ANDREW ALDRIDGE: Open Payments
NPI 1396712659 · MEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100,229 in 159 payments from 8 companies in 2025. Trend: 2023 $103,627 · 2024 $34,886 · 2025 $100,229
Speaker / faculty: $76,637Travel & lodging: $14,126Consulting: $5,500Food & beverage: $3,865Education: $101
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 76 | $60,894 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 58 | $29,243 |
| Teva Pharmaceuticals USA, Inc. | 10 | $7,306 |
| Otsuka America Pharmaceutical, Inc. | 5 | $2,538 |
| ABBVIE INC. | 4 | $112 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $50 |
| Lundbeck LLC | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
Products named: COBENFY, CAPLYTA, UZEDY, REXULTI, AUSTEDO XR, VRAYLAR, FANAPT.
Industry payments across MA — which companies pay providers there.
